BioPorto A/S (THOXF)
OTCMKTS · Delayed Price · Currency is USD
0.2880
+0.0580 (25.22%)
At close: Jun 26, 2024

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Neutrophil Gelatinase-associated Lipocalin Tests
18.56M
Log In
Log In
Log In
Log In
Upgrade
Neutrophil Gelatinase-associated Lipocalin Tests Growth
24.91%
Log In
Log In
Log In
Log In
Upgrade
Antibodies
10.68M
Log In
Log In
Log In
Log In
Upgrade
Antibodies Growth
-11.24%
Log In
Log In
Log In
Log In
Upgrade
Enzyme-linked Immunosorbent Assay Kits
1.67M
Log In
Log In
Log In
Log In
Upgrade
Enzyme-linked Immunosorbent Assay Kits Growth
-8.82%
Log In
Log In
Log In
Log In
Upgrade
Royalty and Other
45.00K
Log In
Log In
Log In
Log In
Upgrade
Royalty and Other Growth
-81.48%
Log In
Log In
Log In
Log In
Upgrade
Other Products and Licenses
-
Log In
Log In
Log In
Log In
Upgrade
Other Products and Licenses Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Neutrophil Gelatinase-associated Lipocalin
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
17.30M
Log In
Log In
Log In
Log In
Upgrade
Europe
9.71M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-3.82%
Log In
Log In
Log In
Log In
Upgrade
Asia
3.77M
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
-3.70%
Log In
Log In
Log In
Log In
Upgrade
North America
179.00K
Log In
Log In
Log In
Log In
Upgrade
North America Growth
-98.80%
Log In
Log In
Log In
Log In
Upgrade
Other Regions
-
Log In
Log In
Log In
Log In
Upgrade
Other Regions Growth
-
Log In
Log In
Log In
Log In
Upgrade